​​

​​Oncology: Breast Cancer

Medicine®, a Wolters Kluwer Health publication and one of the most respected and frequently cited journals in general medicine, is pleased to announce the launch of Medicine®: Breast Cancer, an online channel of content specifically dedicated to the publication and distribution of Breast Cancer-related research within Medicine®.

Medicine®: Breast Cancer will consider submissions in the following subject areas:

  • Diagnosis and Evaluation of Breast Disease
  • Treatment and Management of breast Cancer
  • Pathology and Biological Markers of Invasive Breast Cancer
  • Breast Imaging and Biopsy Techniques
  • Preoperative Systematic Therapy
  • Evaluation After Primary Therapy and Recurring Breast Cancer
  • New Breast Cancer Therapeutic Approaches
  • ​Site-Specific Therapy of Metastatic Breast Cancer

Click here to view the Medicine®: Breast Cancer Editorial Board

Submissions to Medicine®: Breast Cancer will be published and indexed under the Medicine® ISSN.

Submit Your Manuscript

(note: Select section/category "5750 Breast Cancer Channel" during submission process)

​​

Channels

287 results

Current Filters:

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients

Jung, Eun Jung; Kim, Ju-Yeon; Kim, Jae-Myung; More

Medicine. 100(11):e25000, March 19, 2021.

Management of the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: A single-center study

Aksoy, Suleyman Ozkan; Sevinc, Ali Ibrahim; Ünal, Mücahit; More

Medicine. 99(49):e23538, December 4, 2020.

  • Open
  • UNITED STATES

A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy

Ji, Dongmei; Shen, Weina; Zhang, Jian; More

Medicine. 99(44):e22886, October 30, 2020.

Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatment

Watanuki, Rurina; Shimomura, Akihiko; Yazaki, Shu; More

Medicine. 99(38):e22331, September 18, 2020.

Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series

Huang, Jian; Huang, Ping; Shao, Xi-ying; More

Medicine. 99(29):e20821, July 17, 2020.

Combining the tumor abnormal protein test with tests for carcinoembryonic antigens, cancer antigen 15–3, and/or cancer antigen 125 significantly increased their diagnostic sensitivity for breast cancer

Chen, Rui; Jiang, Chaojun; Zhu, Qiannan; More

Medicine. 99(29):e21231, July 17, 2020.

Relationship between perimetric increase and fluoroscopic pattern type in secondary upper limb lymphedema observed by Indocyanine green lymphography

Medina-Rodríguez, María Elena; de-la-Casa-Almeida, María; Mena-Rodríguez, Antonio; More

Medicine. 99(24):e20432, June 12, 2020.

Analysis of breast cancer cases according to county-level poverty status in 3.5 million rural women who participated in a breast cancer screening program of Hunan province, China from 2016 to 2018

Lili, Xiong; Zhiyu, Liu; Yinglan, Wu; More

Medicine. 99(17):e19954, April 2020.

Amenorrhea, fertility preservation, and counseling among young women treated with anthracyclines and taxanes for early-stage breast cancer, a retrospective study

Abdel-Razeq, Hikmat N.; Mansour, Razan A.; Ammar, Khawla S.; More

Medicine. 99(11):e19566, March 2020.

The association between methods of biopsy and survival following breast cancer: A hospital registry based cohort study

Kong, Yek-Ching; Bhoo-Pathy, Nirmala; O’Rorke, Michael; More

Medicine. 99(6):e19093, February 2020.